2016 World Chlamydia Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Suppliers
The report presents a detailed analysis of the Chlamydia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:
Contains 184 pages and 15 tables
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
Contains 184 pages and 15 tables
I. INTRODUCTION
II. CHLAMYDIA WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
Chlamydia Psittaci
Chlamydia Pneumoniae
Chlamydia Trachomatis
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
E. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
II. CHLAMYDIA WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
Chlamydia Psittaci
Chlamydia Pneumoniae
Chlamydia Trachomatis
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
E. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
LIST OF TABLES
Major Companies Developing or Marketing Chlamydia Tests
France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
France Chlamydia Diagnostics Sales by Major Supplier
Germany Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Italy Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Chlamydia Diagnostics Sales by Major Supplier
Spain Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Spain Chlamydia Diagnostics Sales by Major Supplier
U.K. Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Chlamydia Diagnostics Sales by Major Supplier
Major Companies Developing or Marketing Chlamydia Tests
France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
France Chlamydia Diagnostics Sales by Major Supplier
Germany Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Italy Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Chlamydia Diagnostics Sales by Major Supplier
Spain Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Spain Chlamydia Diagnostics Sales by Major Supplier
U.K. Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Chlamydia Diagnostics Sales by Major Supplier
More Publications
2016 Emerging Spanish Diagnostic Testing Market: Segment Forecasts and Supplier Shares by Test
US$ 3,880.00
October 2015
56 pages
2017-2021 Emerging US Diagnostic Testing Market: Segment Forecasts and Supplier Shares by Test
US$ 4,860.00
March 2017
101 pages
2017-2021 Emerging UK Diagnostic Testing Market: Segment Forecasts and Supplier Shares by Test
US$ 4,365.00
March 2017
64 pages
2015-2019 Global Chlamydia Diagnostic Testing Market: Emerging Opportunities and Growth Strategies
US$ 3,480.00
July 2015
184 pages
2015-2019 POC/Point-of-Care Diagnostic Testing Market: Supplier Shares, Country Forecasts for 300 Tests, Emerging Technologies, Competitive Strategies
US$ 22,000.00
September 2015
1230 pages